UNITED
STATES SECURITIES AND
EXCHANGE
COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date
of
Report (Date of earliest event reported): April
24, 2006
GAMMACAN
INTERNATIONAL, INC.
(Exact
name of registrant as specified in its charter)
Delaware
(State
or
other jurisdiction of incorporation)
0-32835
(Commission
File Number)
33-0956433
(IRS
Employer Identification No.)
11
Ben Gurion St., 54100 Givat Shmuel, Israel
(Address
of principal executive offices and Zip Code)
Registrant's
telephone number, including area code: 972
3 5774475
(Former
name or former address, if changed since last report)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
o
Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM
7.01 Regulation FD Disclosure
On
April
24, 2006, Gammacan International, Inc. expects to make a presentation concerning
its business to potential business partners. The materials to be utilized during
the presentation is filed as Exhibit 99.1 to, and incorporated by reference
in,
this report. In accordance with Regulation FD, this current report is being
filed to publicly disclose all information that was provided in its press
release. This report under Item 7.01 is not deemed an admission as to the
materiality of any information in this report that is required to be disclosed
solely by Regulation FD.
ITEM
9.01. Financial Statements and Exhibits.
| 99.1 |
Presentation
Materials.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
| |
GAMMACAN
INTERNATIONAL, INC.
/s/
Chaime
Orlev
Chaime
Orlev,
Chief
Financial Officer
Date:
April 24, 2006
|